PFBT
ITOS

Parkside Financial Bank & Trust’s iTeos Therapeutics ITOS Stock Holding History

Parkside Financial Bank & Trust’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-96
Closed -$1.05K – 2124
2023
Q3 		$1.05K Buy
96
+88
+1,100% +$1.13K ﹤0.01% 1833
2023
Q2 		$106 Buy
+8
New +$114 ﹤0.01% 1997
2023
Q1 		– Sell
-76
Closed -$1.48K – 2062
2022
Q4 		$1.48K Buy
76
+54
+245% +$1.05K ﹤0.01% 1765
2022
Q3 		$0 Hold
22
– – ﹤0.01% 1864
2022
Q2 		$0 Buy
+22
New +$522 ﹤0.01% 1880

Other funds holding ITOS

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Parkside Financial Bank & Trust's ITOS Position: Q4 2023 in Review

Parkside Financial Bank & Trust sold out of iTeos Therapeutics (ITOS) in Q4 2023, closing a stake of 96 shares — an estimated $1.05K sold.

Parkside Financial Bank & Trust first reported a position in ITOS in Q2 2022 and held it in 5 quarters. The position peaked at $1.48K in Q4 2022. 137 funds tracked by Wall St. Rank hold ITOS as of Q4 2023.

  • Parkside Financial Bank & Trust reported no remaining iTeos Therapeutics position as of Q4 2023 after selling out during the quarter.
  • Parkside Financial Bank & Trust sold 96 iTeos Therapeutics shares in Q4 2023, an estimated $1.05K.
  • Parkside Financial Bank & Trust first reported a position in iTeos Therapeutics in Q2 2022 and held it in 5 quarters.
  • Parkside Financial Bank & Trust's iTeos Therapeutics position peaked at $1.48K in Q4 2022.
  • 137 funds tracked by Wall St. Rank held iTeos Therapeutics as of Q4 2023.

Based on Parkside Financial Bank & Trust's 13F filing for Q4 2023, filed 1 Feb 2024.